Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
'''Approved Call Summaries:''' | '''Approved Call Summaries:''' | ||
| − | + | *[[Media:06 11 2021 QIBA CEUS BC Call Summary-FINAL.pdf|June 11, 2021]] | |
*[[Media:05 14 2021 QIBA CEUS BC Call Summary-FINAL.pdf|May 14, 2021]] | *[[Media:05 14 2021 QIBA CEUS BC Call Summary-FINAL.pdf|May 14, 2021]] | ||
*[[Media:04 09 2021 QIBA CEUS BC Call Summary-FINAL-MA.pdf|April 09, 2021]] | *[[Media:04 09 2021 QIBA CEUS BC Call Summary-FINAL-MA.pdf|April 09, 2021]] | ||
Revision as of 16:50, 24 May 2021
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: